Showing results (71-80 of 443) with videos related to
Sort By:
Pageof 45
Journal of Cancer Research and Clinical Oncology|October 21, 2021
Combination of treosulfan, fludarabine and cytarabine as conditioning in patients with acute myeloid leukemia, myelodysplastic syndrome and myeloproliferative neoplasmsSamantha O'Hagan Henderson, Jochen J Frietsch, Inken Hilgendorf, et al.Blood|February 28, 2002
Overexpression of SOCS-2 in advanced stages of chronic myeloid leukemia: possible inadequacy of a negative feedback mechanismBeate Schultheis, Melina Carapeti-Marootian, Andreas Hochhaus, et al.Blood|November 24, 2012
Model-based decision rules reduce the risk of molecular relapse after cessation of tyrosine kinase inhibitor therapy in chronic myeloid leukemiaMatthias Horn, Ingmar Glauche, Martin C Müller, et al.Annals of Hematology|February 27, 2004
Complete molecular remission of chronic eosinophilic leukemia complicated by CNS disease after targeted therapy with imatinibNorbert Frickhofen, Elisabeth Märker-Hermann, Andreas Reiter, et al.Journal of Cancer Research and Clinical Oncology|December 17, 2022
Psychosocial distress in young adults surviving hematological malignancies: a pilot studyAndreas Wittwer, Kristin Sponholz, Jochen J Frietsch, et al.Clinical Pharmacology : Advances and Applications|June 22, 2013
Differential effects of dosing regimen on the safety and efficacy of dasatinib: retrospective exposure-response analysis of a Phase III studyXiaoning Wang, Amit Roy, Andreas Hochhaus, et al.Leukemia|May 6, 2020
Expert opinion-management of chronic myeloid leukemia after resistance to second-generation tyrosine kinase inhibitorsAndreas Hochhaus, Massimo Breccia, Giuseppe Saglio, et al.Journal of Cancer Research and Clinical Oncology|March 25, 2015
Efficacy of antifungal prophylaxis with oral suspension posaconazole during induction chemotherapy of acute myeloid leukemiaKarin G Schrenk, Ulf Schnetzke, Katy Stegemann, et al.Leukemia|January 18, 2024
Lymphoma-associated hemophagocytic lymphohistiocytosis (LA-HLH): a scoping review unveils clinical and diagnostic patterns of a lymphoma subgroup with poor prognosisJohanna Knauft, Thomas Schenk, Thomas Ernst, et al.Leukemia Research|September 4, 2013
The E3 ubiquitin ligase TRAF2 can contribute to TNF-α resistance in FLT3-ITD-positive AML cellsUlf Schnetzke, Mike Fischer, Bärbel Spies-Weisshart, et al.Pageof 45